Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreNew Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreNew Delhi: An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation (EUA) to Bharat Biotech’s ...
Read moreNew Delhi: Zydus Cadila Thursday said it has applied for emergency use authorisation (EUA) with the Drug Controller General of ...
Read moreNew Delhi: India’s drug regulator Drugs Controller General of India (DCGI) has granted permission to Cipla to import Moderna's Covid-19 ...
Read moreNew Delhi: Bharat Biotech’s Covaxin is 77.8 per cent effective in protecting against Covid-19, according to data from Phase III ...
Read moreNew Delhi: Zydus Cadila announced Thursday that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies (mAbs) can ...
Read moreNew Delhi: The Delhi High Court Wednesday sought the Centre's response on a plea seeking to set aside the permission ...
Read moreNew Delhi: India’s drug regulator has granted permission for the restricted emergency use of Russian COVID-19 vaccine ‘Sputnik V’ with certain conditions. It ...
Read moreNew Delhi: Pharma major Pfizer announced Friday withdrawal of its application for emergency use authorisation of its COVID-19 vaccine in ...
Read moreNew Delhi: The Covaxin vaccine developed by Hyderabad-based Bharat Biotech is effective against UK variants of COVID-19. This information was ...
Read more